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Abstract
Background: Despite the expansion of antenatal syphilis screening programs, congenital syphilis (CS) remains a concern.
Purpose: This study aimed to analyze the manifestation and progress of CS, including treatment and follow-up, based on
a nationwide study.
Methods: From the Korean National Health Insurance Service database, a total of 548 infants were examined for CS
during their first year of life from 2013 to 2018. Neurosyphilis and complications were investigated using the International
Classification of Diseases-10 codes.
Results: The birth rate of infants from mothers with syphilis was 2.8 per 10,000 live births for 5 years, which is not
indicative of a decreasing trend. Overall, 148 infants were proven or highly probable or possible of having CS with
treatment for 10 days; 66 infants were possible or less likely of having CS with only 1-day treatment. Jaundice (56 %) was
common, followed by hearing impairment (14 %), renal disease (8 %), and mental retardation (8 %). Fourteen cases of
neurosyphilis occurred. Infants with complications, including mental retardation, eye involvement, hearing impairment, or
renal disease, were significantly associated with neurosyphilis (OR 8.49, P < 0.0001). Of 250 patients who received
treatment, 92.8 % were treated with one medication: benzathine penicillin was used in 73% of patients. Only four
patients were re-treated due to treatment failure. In addition to the treponemal test, fluorescent treponemal antibody-
absorption was the most utilized tool for diagnosis and follow-up.
Conclusions: Establishing standardized guidelines for the evaluation of CS, as well as the establishment of treatment
regimens and follow up-plans for the disease, at a national level would help improve maternal and neonatal care and
facilitate the eradication of CS in Korea.
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Background
Congenital syphilis (CS), caused by Treponema palli-
dum, can be passed from the mother to infant in utero
or at birth by exposure to infected maternal lesions. CS
is a cause of considerable morbidity and mortality
worldwide [1]. Syphilis is generally thought to be
eradicated, although it still remains in both developing
and developed countries [2, 3]. The World Health
Organization (WHO) estimates that approximately one
million pregnant women around the world are infected
with syphilis each year [4]. Meanwhile, in Korea, the
sentinel surveillance system, which started in 2001, has
recorded increases in the number of CS cases. A total of
94 cases were reported between 2001 and 2010, while 99
cases were reported from 2011 to 2014 [5]. According to
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data from the Korea Centers for Disease Control and
Prevention, the rates of syphilis and congenital syphilis
in 2014 were 1.42 cases per 100,000 people and 0.05
cases per 100,000 [6].
Untreated syphilis during pregnancy is transmitted in
> 70 % of affected infants, and fetal or perinatal death oc-
curs in 40 %. Unfortunately, more than two-thirds of live
neonates born to untreated or inadequately treated
mothers does not present any symptom at first. How-
ever, there are few national reports on infants with CS.
A study in Louisiana and Florida from 2013 to 2014
showed that 20.3 % of a total of 3,497 syphilis cases were
found in pregnant women, and mother-to-child trans-
mission occurred in 22 %, leading to five stillbirths and
five deaths after birth due to CS. Thus, for every 4.6
pregnant women with syphilis, there was one case of CS.
Therefore, all neonates born to mothers with reactive
nontreponemal/treponemal test results are recom-
mended to do a quantitative nontreponemal test using
neonate’s serum and be considered for proper treatment.
Treatment should be decided on the basis of identifi-
cation of syphilis in the mother; adequacy of maternal
treatment; presence of clinical, laboratory, or radiologic
evidence of syphilis in neonate; and comparison of ma-
ternal and neonatal serologic titers. Clinical symptoms
are divided into early signs which appears in the first
2 years of life and late signs developing later over the
first two decades of life [7]. Symptoms such as hearing
loss, hydrocephalus, optic nerve atrophy, and mental re-
tardation require follow-up for at least 2 years [8]. Renal
involvements may vary from simple albuminuria to sig-
nificant nephritis or nephrotic syndrome [7, 9]. Physi-
cians should be aware of the various clinical features of
syphilis to enable early diagnosis. However, data on the
clinical manifestations and long-term outcomes of CS
are limited.
Although CS is a preventable disease, its incidence has
not decreased in the last 10 years. As understanding of
the neonatal outcomes of pregnant women with syphilis
could help with deciding on the appropriate treatment,
this study sought to analyze the manifestations and pro-
gression of CS, including treatment and follow-up.
Methods
The Korean National Health Insurance Service (NHIS)
stores healthcare data, such as diagnostic codes, diagnostic
tests, procedures, and prescription medications, for Ko-
rean residents. Nearly 98 % of Korean residents are cov-
ered by the NHIS and 2 % are covered by medical aid
[10]. NHIS records also include demographic data of the
beneficiaries, such as age, sex, residential area, and income
status [11]. From the NHIS-NSC data for 2014–2018, we
selected infants under 1 year of age who underwent non-
treponemal and/or treponemal tests and were diagnosed
with CS (International Classification of Diseases-10 codes:
A50.0, A50.1, A50.2, A50.9). Finally, a total of 548 infants
were followed up from the date of testing for CS to De-
cember 31, 2018. We used birth statistics to estimate the
prevalence of CS based on the number of live births
[12]. The International Classification of Diseases-10 codes
were used to determine the infants with clinical manifesta-
tions or complications, including jaundice, hepatospleno-
megaly, ascites, renal disease, optic nerve atopy, hearing
impairment, mental retardation, intrauterine growth re-
tardation, and hydrops fetalis. Neurosyphilis with positive
cerebrospinal fluid VDRL was confirmed for infants diag-
nosed with the International Classification of Diseases-10
codes A52.1, A52.2, A52.3, and A50.4. Benzathine penicil-
lin or aqueous penicillin was used for treatment.
Statistical analyses
The cohort was stratified by the study year. One-way
ANOVA and t tests were used to compare the neonatal
characteristics and complications among different
groups. We analyzed the data by using SAS version 9.4
(SAS Institute, Cary, North Carolina). P values < 0.05
were considered statistically significant.
Ethics statement
In this work, all identifiable variables, including claim-,
individual-, and organizational-level identification num-
bers, were re-generated randomly and anonymized be-
fore its use to protect patient’s privacy. This study used
NHIS data (NHIS-2020-1-100) made by NHIS. We ob-
tained adequate administrative permissions of NHIS to
use the data for research purposes. We ensure the secur-
ity of the data and confidentiality of the information
contained in the data. The study protocol was approved
by the Institutional Review Board (IRB) of Gangnam
Severance Hospital (IRB No. 3-2019-0147).
Results
A total of 548 infants born between 2014 and 2018 were
evaluated with a nontreponemal test for the diagnosis of
CS. Reflective of a steady rate, the birth rate of infants
from mothers with syphilis was 2.8 per 10,000 live births
during the 5-year period. The preterm birth rate was 0.5
per 10,000 live births, and the term birth rate was 3.0
per 10,000 live births. Prevalence distribution according
to province is shown in Fig. 1. Seoul and its surrounding
areas showed a lower incidence of CS compared to other
regions.
Among 548 infants, CS was considered unlikely in 298
infants. Overall, 148 infants who were proven or consid-
ered highly probable or possible of having CS were treated
for 10 days. Meanwhile, 66 infants with possible or less
probable CS were treated for only 1 day with benzamine
penicillin. Males accounted for 53.4 % of all cases.
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Jaundice was the most common symptom (56 %),
followed by hearing impairment (14 %), renal disease
(8 %), and mental retardation (8 %). Small for gestational
age or intrauterine growth restriction was observed in
6 % of cases (Table 1). A total of 14 cases of neurosyph-
ilis occurred over the 5-year study period. Among
neurosyphilis patients, mental retardation occurred in
one patient, and hearing impairment occurred in six
patients. Hearing impairment was more frequent in
patients with neurosyphilis than in those without (P <
0.0001). Complications including mental retardation, eye
involvement, hearing impairment, and renal disease were
significantly associated with neurosyphilis (OR, 8.49;
95 % CI, 2.7–26.6; P < 0.0001). Infants treated with aque-
ous penicillin showed a higher risk of complications
compared to those treated with benzathine penicillin
(OR, 2.42; 95 % CI, 1.1–6.2; P < 0.0001). Syphilis com-
bined with noted complications tended to increase the
risk of treatment failure, which resulted in prolonged
treatment duration (OR, 1.09; 95 % CI, 1.03–1.15;
p = 0.0005; Table 2). Sex, preterm birth, and birth year
did not significantly affect the rate of complications.
Among 250 patients who underwent treatment, 92.8 %
were treated with one medication (aqueous crystalline
penicillin G or benzathine penicillin G); benzathine
penicillin was used in 73 % of patients. Eighteen patients
received both benzathine penicillin G and aqueous crys-
talline penicillin G (Table 3). Only four patients were re-
treated due to treatment failure: one each at 2 weeks, 1
month, 3 months, and 6 months. Two received aqueous
crystalline penicillin G, and the other two received both
aqueous crystalline penicillin G and benzathine penicil-
lin G, with an average treatment duration or median
duration (Table 3 shows median treatment durations).
There were no sex disparities therein, and all births were
full term. The re-treatment group comprised one infant
with renal involvement and one infant with hearing im-
pairment. The treatment durations for the initial
Fig. 1 Prevalence of infants born to mothers with syphilis by region (/10,000 births). This figure was designed by medical illustration & design of
medical research support section, Yonsei University College of Medicine, Seoul, Korea
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treatment were 1 day in one infant and 10 and 16 days,
respectively, in the other two infants.
The numbers and methods of treponemal tests for
follow-up in 2018 are described in Table 4. In addition
to the nontreponemal test, fluorescent treponemal
antibody-absorption (FTA-ABS) was the most utilized
tool for diagnosis during follow-up; treponemal pallidum
particle agglutination was the second most commonly
used method.
Discussion
Despite the expansion of antenatal syphilis screening
programs over the past few decades, syphilis continues
to be a major public health concern worldwide. This is
the first nationwide study on the manifestation and
treatment of CS in Korea. Given the chances of transpla-
cental transmission during pregnancy at any stage of
maternal disease [13], the WHO launched a global ini-
tiative against mother-to-child transmission of syphilis
in 2007, by promoting antenatal screenings in the first
and third trimesters in all pregnant woman. Currently in
Korea, pregnant women are routinely tested for syphilis
at the beginning of pregnancy, and those who are at high
risk of syphilis are advised to take an additional test in
the third trimester. However, in recent years, CS has re-
emerged in both developing and higher income coun-
tries, including the United States and Canada [14, 15].
Syphilis in Korean adults decreased from 2.5 % in 1977
to 0.2 % in 2000. The number of CS cases declined be-
tween 2008 and 2012, followed by another sharp in-
crease from 2012 to 2014, with an increase from 8.4 to
11.6 cases per 100,000 live births [16]. Based on our data
over the last 5 years, we noted that while the number of
syphilis patients has tended to decrease, the prevalence
of CS has fluctuated, ranging between 1.4 to 3.8 % for
the past 5 years, which could be attributed to the
Table 2 Comparisons of characteristics between infants with
and without complications of congenital syphilis






2014 16 (21 %) 60 (79 %) 0.4626
2015 15 (22 %) 53 (78 %)
2016 9 (21 %) 34 (79 %)
2017 8 (25 %) 24 (75 %)
2018 3 (3 %) 32 (91 %)
Male 21 (41 %) 108 (53 %) 0.1248
Preterm 0 (0 %) 7 (3 %) 0.6155
Neurosyphilis 7 (14 %) 7 (3 %) < 0.0001
Aqueous penicillin 7 (14 %) 57 (28 %) 0.0394
Benzathine penicillin 39 (76 %) 131 (63 %)
Duration of Tx ≥ 10 48 (6 %) 165 (17 %) 0.1691
MR mental retardation, Tx treatment
Table 3 Treatment drugs and duration
Initial treatment
N = 250
Treatment with one drug, n (%) 232 (93 %)
Aqueous crystalline penicillin G, n (%) 80 (32 %)
Benzathine penicillin G, n (%) 182 (73 %)
Duration of treatment 1 day, n (%) 66 (26 %)
2–9 days, n (%) 36 (14 %)
≥10 days, n (%) 148 (59 %)
Re-treatment
N = 4
Treatment with one drug, n (%) 2 (50 %)
Aqueous crystalline penicillin G, n (%) 2 (50 %)
Benzathine penicillin G, n (%) 4 (100 %)
Duration of treatment, median (range) 15.5 (3–26)













Prevalence /10,000 births 3.86 2.78 2.42 1.96 2.78 2.80
Male, n (%) 39 (50) 32 (57) 23(51) 16 (49) 24 (61) 134 (54)
Preterm, n (%) 3 (4) 1 (2) 0 (0) 0 (0) 1 (3) 5 (1)
Jaundice, n (%) 48 (62) 31 (58) 23 (51) 14 (45) 24 (59) 140 (56)
Hepatosplenomegaly, n (%) 2 (3) 1 (2) 0 (0) 0 (0) 1 (3) 4 (1)
Ascites, n (%) 2 (3) 1 (2) 1 (2) 0 (0) 1 (3) 5 (2)
Renal disease, n (%) 7 (9) 5 (9) 5 (11) 2 (6) 2 (5) 21 (8)
Optic nerve atrophy, n (%) 0 (0) 0 (0) 1 (2) 0 (0) 0 (0) 1 (0)
Hearing impairment, n (%) 12 (16) 8 (14) 7 (16) 6 (19) 1 (3) 34 (14)
Mental retardation, n (%) 8 (10) 7 (13) 4 (9) 0 (0) 0 (0) 19 (8)
IUGR or SGA, n (%) 4 (5) 3 (5) 3 (7) 3 (9) 2 (5) 15 (6)
Hydrops fetalis, n (%) 1 (1) 0 (0) 0 (0) 0 (0) 0 (0) 1(0)
IUGR intrauterine growth restriction, SGA small for gestational age
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increasing prevalence of marriages between Koreans and
non-Koreans [5].
Seoul and its surrounding areas showed a lower inci-
dence of syphilis compared to other regions. The disease
prevalence tended to be removed with further distance
from the capital and surrounding areas. This could be
related to variations in antenatal care systems and pa-
tient compliance to antenatal care. Indeed, a higher inci-
dence of CS in immigrant mothers has been reported
due to failure of prenatal care [5]. Also, a higher inci-
dence of gestational syphilis was observed in women of
lower socioeconomic status and women with lower edu-
cation [17, 18]. In this study, socioeconomic data were
not included, and only trends by region could be seen.
Intrauterine infection can result in spontaneous
abortion, hydrops fetalis, preterm birth, and low birth
weight. Clinical manifestations in infected infants
within the first 1–2 months of age include hepatospleno-
megaly, lymphadenopathy, rash, mucocutaneous lesions,
copious nasal secretions, pneumonia, hemolytic anemia,
thrombocytopenia, and skeletal involvement [19]. Due to
the limited maternal information in the current study,
syphilis-related stillbirths/abortions were not included.
Only one case of hydrops fetalis was noted, and the preva-
lence of preterm births was 0.495 per 10,000 births, com-
pared to 2.976 per 10,000 births for term births. There
was no case of mortality after birth. Over the last 5 years,
male patients showed a non-significantly higher preva-
lence (53 %), similar to temporal studies conducted in the
United Kingdom and Brazil [20, 21].
The surveillance of neurosyphilis, an uncommon but
severe consequence of syphilis, is complex [22, 23]. Out
of 14 patients (2.5 %) with neurosyphilis, mental retard-
ation occurred in one case, and hearing impairment oc-
curred in six patients (43 %). As early diagnosis and
treatment are important to prevent late manifestations
of the infection, we wish to emphasize the importance of
screening for neurosyphilis in asymptomatic patients,
even if symptoms are lacking for a diagnosis of syphilis,
as the central nervous system is crucial for neurodeve-
lopmental outcomes.
While the prognosis is considered to be very good for
infected infants treated during the first 2 months of life,
if left untreated, disease progression may lead to death
or disability in children [24]. In our study, no death was
noted; however, over 20 % of the subjects suffered from
complications such as mental retardation, eye and renal
involvement, and hearing impairment. The presence of
complications led to a prolonged duration of treatment.
Complication rates were similar throughout the 5 years,
except in 2018, potentially reflecting the timepoint of
data collection. Patients who received aqueous penicillin
G had more complications and neurosyphilis compared
to those who received benzathine penicillin G. Sex and
preterm infants were not significantly associated with
complication risk. In addition to high-quality antenatal
screening and care, early detection of neurosyphilis and
appropriate treatment indications with benzathine peni-
cillin G can also improve the prognosis.
The recommended duration of treatment for definite
or probable CS is intravenous penicillin G for 10 days. If
more than 1 day of therapy is missed, the whole course
must be started again. In infants with possible syphilis, a
single intramuscular dose of benzathine penicillin is an
alternative treatment choice in select circumstances, but
only if follow-up is assured [25]. According to our data,
benzathine penicillin G is prescribed more frequently
than aqueous crystalline penicillin G, with a variable
treatment duration. Four patients underwent re-
treatment with various manifestations, treatment regi-
mens, and durations, which may be due to the rare
prevalence of the disease and site differences. This re-
flects the lack of standard guidelines for evaluation and
therapeutic measures of CS.
Once CS is diagnosed, serial laboratory follow-up is re-
quired to assess the duration of treatment [26]. In this
study, the number of tests during serial follow-up varied
from one to four. Testing methods also varied. Reverse









Number of tests 1 38 (63 %) 5 (45 %) 3 (60 %) 0 (0 %)
2 15 (25 %) 4 (36 %) 1 (20 %) 1 (100 %)
3 7 (12 %) 1 (9 %) 1 (20 %) 0 (0 %)
4 0 (0 %) 1 (9 %) 0 (0 %) 0 (0 %)
Test method TPPA 20 (33 %) 8 (73 %) 3 (60 %) 0 (0 %)
EIA 20 (33 %) 5 (45 %) 4 (80 %) 1 (100 %)
FTA-ABS 48 (80 %) 6 (55 %) 1 (20 %) 1 (100 %)
PCR 1 (2 %) 0 (0 %) 3 (60 %) 0 (0 %)
TPPA treponema pallidum particle agglutination, EIA enzyme immunoassay, FTA-ABS fluorescent treponemal antibody absorbed test, PCR polymerase
chain reaction
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sequence testing is emerging as a high throughput and
cost-effective method for screening syphilis [27]; how-
ever, it is still limited in the clinical setting. Meanwhile,
out data have shown different algorithms of follow-up
tests between sites. Considering the scarce prevalence of
CS, it is important to share a standardized algorithm for
the evaluation and treatment of CS at the national level
to improve treatment outcomes.
In Korea, cases of CS have been reported occasionally
in specific case reports. There are no published data with
yearly long-term follow-up. Differences in the numbers
reported in the Centers for Disease Control (10–33 in-
fants with proven CS) and NHIS databases indicate the
clinical complexity of diagnosis and limitations of self-
reporting. A strength of our study was that it used na-
tionwide accumulative data with updates on recent rates
of CS, including long-term complications.
A limitation of this study was that it depended on in-
fant claim data; therefore, maternal information, includ-
ing adequate treatment, spontaneous abortion, and
stillbirths, were not included. Data analysis after 2018
can add some additional trends and outcomes of CS.
The data did not have records collected from laborator-
ies, notably on the severity of conditions and health be-
havior of beneficiaries. Since the information was
obtained from the diagnosis code entered by each hos-
pital, there could be data omission or limited detailed in-
formation about the diseases of each subject. There
could be a discrepancy between the diagnoses entered in
the database and the actual diseases that the patients
had. Furthermore, as the claims data were generated to
reimburse healthcare services eligible for coverage, non-
covered healthcare services were not assessed. Informa-
tion about the residence of beneficiaries may not be reli-
able, since HIRA data are collected based on the
location of providers; therefore, a beneficiary may have
received healthcare services in a different area from
where they actually reside.
Another limitation of our study was that it only in-
cluded infants born in Korea, and the results may not be
generalizable to other regions in the world.
Conclusions
In conclusion, although antenatal syphilis screening pro-
grams have expanded, CS still remains a problem in
Korea. Due to the rarity of CS, sharing standardized
guidelines for evaluating CS as well as establishing treat-
ment regimens and follow-up plans at a national level
are required to improve the quality of maternal and neo-
natal care, which could lead to the eradication of CS.
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